Beta-lactam exposure and safety in intermittent or continuous infusion in critically ill children: an observational monocenter study.

• Continuous infusion provided a higher probability to attain an optimal pharmacokinetic target compared to intermittent infusion, but also a higher risk of overexposure. • Regular therapeutic drug monitoring is recommended in critically ill children receiving beta-lactams, regardless of the length of infusion.